Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 3;13(11):2791. doi: 10.3390/cancers13112791

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Landscape of genomic alterations identified by targeted deep sequencing in EUS-FNB specimens of patients with PDAC. (A) Co-mutation plot displaying integrated genomic data for 116 EUS-FNB specimens displayed as columns, including somatic mutations and somatic copy number variations for significantly mutated genes listed at the right (Top 10). The percentage of PDAC samples with an alteration of any type is noted at the left. Stage, age, sex, CA19-9 level, tumor mass size, and the number of any genetic alterations per each sample is presented on the top. Overall survival (OS) of each patient is shown on the bottom. (B) Variant allele frequency (VAF) distributions are analyzed, and median values are indicated by the central bar in the box and whiskers plots. PDAC, pancreatic ductal adenocarcinoma; EUS-FNB, endoscopic ultrasound-guided fine-needle biopsy; AMP, copy number amplification; DEL, copy number deletion; FUSION, structure variation; TRUNC, truncating mutation; NONTRUNC, non-truncating mutation.